Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Share:
Related GILD
Verastem's CEO Talks DYNAMO Study, The Competitive Landscape And Pitch To Investors
Orphan Drugs Among 2015's Top 10 Best-Selling Medications
How Will Gilead Fare In 2017? (Seeking Alpha)
Related CELG
Orphan Drugs Among 2015's Top 10 Best-Selling Medications
Oppenheimer Upgrades Agios Pharma On Expectations For First Drug Launch
Raymond James Trust N.a. Buys WisdomTree Japan Hedged Equity Fund, United Technologies Corp, ... (GuruFocus)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

View Comments and Join the Discussion!